177 related articles for article (PubMed ID: 20088394)
1. Studies on CYP1A1, CYP1B1 and CYP3A4 gene polymorphisms in breast cancer patients.
Ociepa-Zawal M; Rubiś B; Filas V; Breborowicz J; Trzeciak WH
Ginekol Pol; 2009 Nov; 80(11):819-23. PubMed ID: 20088394
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the influence of polymorphic variants CYP1A1 2B, CYP1B1 2, CYP3A4 1B, GSTM1 0, and GSTT1 0 in prostate cancer.
Rodrigues IS; Kuasne H; Losi-Guembarovski R; Fuganti PE; Gregório EP; Kishima MO; Ito K; de Freitas Rodrigues MA; de Syllos Cólus IM
Urol Oncol; 2011; 29(6):654-63. PubMed ID: 20884258
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of the ERalpha and CYP1B1 genes in endometrial cancer in a Polish subpopulation.
Sliwinski T; Sitarek P; Stetkiewicz T; Sobczuk A; Blasiak J
J Obstet Gynaecol Res; 2010 Apr; 36(2):311-7. PubMed ID: 20492382
[TBL] [Abstract][Full Text] [Related]
4. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
Wenzlaff AS; Cote ML; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
Carcinogenesis; 2005 Dec; 26(12):2207-12. PubMed ID: 16051642
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer.
Diergaarde B; Potter JD; Jupe ER; Manjeshwar S; Shimasaki CD; Pugh TW; Defreese DC; Gramling BA; Evans I; White E
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1751-9. PubMed ID: 18628428
[TBL] [Abstract][Full Text] [Related]
6. Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population.
Yousef AM; Bulatova NR; Newman W; Hakooz N; Ismail S; Qusa H; Zahran F; Anwar Ababneh N; Hasan F; Zaloom I; Khayat G; Al-Zmili R; Naffa R; Al-Diab O
Mol Biol Rep; 2012 Oct; 39(10):9423-33. PubMed ID: 22722998
[TBL] [Abstract][Full Text] [Related]
7. Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China.
Wang Q; Li H; Tao P; Wang YP; Yuan P; Yang CX; Li JY; Yang F; Lee H; Huang Y
DNA Cell Biol; 2011 Aug; 30(8):585-95. PubMed ID: 21438753
[TBL] [Abstract][Full Text] [Related]
8. CYP1A1 and CYP1B1 genetic polymorphisms, smoking and breast cancer risk in a Finnish Caucasian population.
Sillanpää P; Heikinheimo L; Kataja V; Eskelinen M; Kosma VM; Uusitupa M; Vainio H; Metsola K; Hirvonen A
Breast Cancer Res Treat; 2007 Sep; 104(3):287-97. PubMed ID: 17063266
[TBL] [Abstract][Full Text] [Related]
9. African American-preponderant single nucleotide polymorphisms (SNPs) and risk of breast cancer.
Kato I; Cichon M; Yee CL; Land S; Korczak JF
Cancer Epidemiol; 2009 Jul; 33(1):24-30. PubMed ID: 19679043
[TBL] [Abstract][Full Text] [Related]
10. Functional evaluation of novel single nucleotide polymorphisms and haplotypes in the promoter regions of CYP1B1 and CYP1A1 genes.
Han W; Pentecost BT; Spivack SD
Mol Carcinog; 2003 Jul; 37(3):158-69. PubMed ID: 12884367
[TBL] [Abstract][Full Text] [Related]
11. Is genetic polymorphism of ER-α, CYP1A1, and CYP1B1 a risk factor for uterine leiomyoma?
El-Shennawy GA; Elbialy AA; Isamil AE; El Behery MM
Arch Gynecol Obstet; 2011 Jun; 283(6):1313-8. PubMed ID: 20559649
[TBL] [Abstract][Full Text] [Related]
12. The redox protein thioredoxin-1 regulates the constitutive and inducible expression of the estrogen metabolizing cytochromes P450 1B1 and 1A1 in MCF-7 human breast cancer cells.
Husbeck B; Powis G
Carcinogenesis; 2002 Oct; 23(10):1625-30. PubMed ID: 12376470
[TBL] [Abstract][Full Text] [Related]
13. Associations between breast cancer susceptibility gene polymorphisms and clinicopathological features.
Han W; Kang D; Park IA; Kim SW; Bae JY; Chung KW; Noh DY
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):124-30. PubMed ID: 14734460
[TBL] [Abstract][Full Text] [Related]
14. Ethnic-related differences in the frequency distribution of genetic polymorphisms in the CYP1A1 and CYP1B1 genes in Japanese and Caucasian populations.
Inoue K; Asao T; Shimada T
Xenobiotica; 2000 Mar; 30(3):285-95. PubMed ID: 10752643
[TBL] [Abstract][Full Text] [Related]
15. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer.
Bailey LR; Roodi N; Dupont WD; Parl FF
Cancer Res; 1998 Nov; 58(22):5038-41. PubMed ID: 9823305
[TBL] [Abstract][Full Text] [Related]
16. CYP1A1 (Ile462Val), CYP1B1 (Ala119Ser and Val432Leu), GSTM1 (null), and GSTT1 (null) polymorphisms and bladder cancer risk in a Turkish population.
Berber U; Yilmaz I; Yilmaz O; Haholu A; Kucukodaci Z; Ates F; Demirel D
Asian Pac J Cancer Prev; 2013; 14(6):3925-9. PubMed ID: 23886208
[TBL] [Abstract][Full Text] [Related]
17. Combinations of cytochrome P-450 genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study.
Cote ML; Wenzlaff AS; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
Lung Cancer; 2007 Mar; 55(3):255-62. PubMed ID: 17174438
[TBL] [Abstract][Full Text] [Related]
18. CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility.
Hirata H; Hinoda Y; Okayama N; Suehiro Y; Kawamoto K; Kikuno N; Rabban JT; Chen LM; Dahiya R
Cancer; 2008 May; 112(9):1964-73. PubMed ID: 18318428
[TBL] [Abstract][Full Text] [Related]
19. Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer among African-American and white women.
Li Y; Millikan RC; Bell DA; Cui L; Tse CK; Newman B; Conway K
Breast Cancer Res; 2004; 6(4):R460-73. PubMed ID: 15217514
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women.
Miyoshi Y; Noguchi S
Biomed Pharmacother; 2003 Dec; 57(10):471-81. PubMed ID: 14637391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]